ECRG4 and diabetes mellitus: Recent studies have identified hyperglycemia driven DNA methylation in diabetic patients [55–57], supporting a hypothesis that hypermethylation of the ECRG4 promoter in diabetics may lead to its decreased expression and subsequent overexpression of neutrophil adhesion molecules as a mechanism for impaired neutrophil recruitment in this disease.